GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
4CQW | Q207Z6 | H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin in Complex with Avian Receptor Analogue 3'SLN | |
4CQY | Q207Z6 | H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin in Complex with Avian Receptor Analogue LSTa | |
4CQX | Q207Z6 | H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin in Complex with Human Receptor Analogue 6'SLN | |
4BH1 | Q207Z6 | H5 (tyTy) Influenza Virus Haemagglutinin in Complex with Avian Receptor Analogue 3'-SLN | |
4BH0 | Q207Z6 | H5 (tyTy) Influenza Virus Haemagglutinin in Complex with Human Receptor Analogue 6'-SLN | |
3ZNK | Q6DQ34 | H5 Haemagglutinin in Complex with 6-O-Sulfo-2,3-Sialyllactosamine (Sulfated 3'SLN) | |
3ZNL | Q6DQ34 | H5 Haemagglutinin in Complex with 6-O-Sulfo-Sialyl-Lewis X (Sulfated Lewis X) | |
3ZNM | Q6DQ34 | H5 Haemagglutinin in Complex with Sialyl-Lewis X | |
8OWV | 8OWV | H6 and F2 nanobodies bound to SARS-CoV-2 spike RBD | |
8OWV | P0DTC2 | H6 and F2 nanobodies bound to SARS-CoV-2 spike RBD | |
6MLM | B2LVD7 | H7 HA0 in complex with Fv from H7.5 IgG | |
6MLM | 6MLM | H7 HA0 in complex with Fv from H7.5 IgG | |
1TI8 | Q6GYW3 | H7 Haemagglutinin | |
1TI8 | Q701T7 | H7 Haemagglutinin | |
4BSI | G0KQM4 | H7N3 Avian Influenza Virus Haemagglutinin in Complex with Avian Receptor Analogue 3'-SLN | |
4BSH | Q6GYW3 | H7N3 Avian Influenza Virus Haemagglutinin in Complex with Human Receptor Analogue 6'-SLN | |
8IUY | A0A2D0Z8H0 | H7N9 HA-1H9 Fab | |
8IUY | 8IUY | H7N9 HA-1H9 Fab | |
8IUZ | A0A2D0Z8H0 | H7N9 HA-2D7 Fab | |
8IUZ | 8IUZ | H7N9 HA-2D7 Fab | |
8IV0 | A0A2D0Z8H0 | H7N9 HA-C4H4 Fab | |
8IV0 | 8IV0 | H7N9 HA-C4H4 Fab | |
3AJ6 | P46084 | HA1 (HA33) mutant F179I of botulinum type C progenitor toxin complexed with N-acetylgalactosamine, bound at site II | |
3AJ5 | P46084 | HA1 (HA33) subcomponent of botulinum type C progenitor toxin complexed with N-acetylgalactosamine, bound at site II | |
3AH2 | P46084 | HA1 subcomponent of botulinum type C progenitor toxin complexed with N-acetylgalactosamine | |
3AH1 | P46084 | HA1 subcomponent of botulinum type C progenitor toxin complexed with N-acetylneuramic acid | |
3AH4 | P46084 | HA1 subcomponent of botulinum type C progenitor toxin complexed with galactose | |
4LO1 | Q45871 | HA17-HA33-Gal | |
4LO1 | Q45878 | HA17-HA33-Gal | |
4LO2 | Q45871 | HA17-HA33-Lac | |
4LO2 | Q45878 | HA17-HA33-Lac | |
4LO3 | Q45871 | HA17-HA33-LacNac | |
4LO3 | Q45878 | HA17-HA33-LacNac | |
2ZOE | P46085 | HA3 subcomponent of Clostridium botulinum type C progenitor toxin, complex with N-acetylneuramic acid | |
4LO5 | Q8KHU9 | HA70-alpha2,3-SiaLC | |
4LO6 | Q8KHU9 | HA70-alpha2,6-SiaLC | |
2L65 | Q8KNF0 | HADDOCK calculated model of the complex of the resistance protein CalC and Calicheamicin-Gamma | |
2LL4 | Q9XZH7 | HADDOCK structure of TgMIC4-A5/lacto-N-biose complex, based on NOE-derived distance restraints | |
7S0K | M1V8A6 | HAP2 from Cyanidioschyzon merolae | |
8C44 | A0A0L7KL67 | HB3VAR03 apo headstructure (PfEMP1 A) complexed with EPCR | |
8C44 | Q9UNN8 | HB3VAR03 apo headstructure (PfEMP1 A) complexed with EPCR | |
8TCO | Q69155 | HCMV Trimer in complex with CS2it1p2_F7K Fab and CS4tt1p1_E3K Fab | |
8TCO | Q8JP80 | HCMV Trimer in complex with CS2it1p2_F7K Fab and CS4tt1p1_E3K Fab | |
8TCO | Q71DI2 | HCMV Trimer in complex with CS2it1p2_F7K Fab and CS4tt1p1_E3K Fab | |
8TCO | 8TCO | HCMV Trimer in complex with CS2it1p2_F7K Fab and CS4tt1p1_E3K Fab | |
9DIX | A8T7F0 | HCMV gH/UL116/UL141 3-mer complex, ectodomain | |
9DIX | Q6RJQ3 | HCMV gH/UL116/UL141 3-mer complex, ectodomain | |
9DIX | A8T7J8 | HCMV gH/UL116/UL141 3-mer complex, ectodomain | |
7KDD | P13201 | HCMV postfusion gB in complex with SM5-1 Fab | |
7KDD | 7KDD | HCMV postfusion gB in complex with SM5-1 Fab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024